Aterian director David Lazar reports no share holdings
Aterian, Inc. director David E. Lazar filed a Form 3 indicating that he does not beneficially own any shares of the company’s Common Stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Aterian, Inc. director David E. Lazar filed a Form 3 indicating that he does not beneficially own any shares of the company’s Common Stock. The filing shows total Common Stock holdings of 0.0000 shares, with a footnote stating that no shares of Common Stock are beneficially owned.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Common Stock | -- | -- | -- |
Footnotes (1)
- F1. No shares of Common Stock are beneficially owned.
Key Figures
Key Terms
Common Stock financial
beneficially owned financial
Form 3 regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does David E. Lazar’s Form 3 for ATER show?
Is the Form 3 for Aterian’s David E. Lazar a buy or sell transaction?
What ownership type is reported for David E. Lazar’s Aterian holdings?
Does Aterian’s Form 3 show any derivative positions for David E. Lazar?
AI-generated analysis. How Rhea-AI works. Not financial advice.